Wadhwani AI wins global challenge for diabetic retinopathy tool
By Abha Lohia · Editor ·
Wadhwani AI: funding and every story →
- Wadhwani AI is a not-for-profit institute working in health, agriculture and education
- It won the 'AI for ALL: Global Impact Challenge' at India AI Impact Summit 2026 for MadhuNetrAI
- MadhuNetrAI has screened over 10,000 patients across 40 healthcare facilities in 11 states
What happened
- Wadhwani AI and AIIMS New Delhi won the 'AI for ALL: Global Impact Challenge' at the India AI Impact Summit 2026.
- The award was for MadhuNetrAI, an AI tool that detects diabetic retinopathy from retinal images.
- The challenge drew over 4,600 applications from more than 60 countries.
- MadhuNetrAI was developed under the guidance of the Ministry of Health and Family Welfare.
- The tool supports frontline healthcare workers like nurses and optometrists in grading and triaging cases.
- It has processed around 20,000 retinal images and screened more than 10,000 patients.
- The tool identified over 3,000 referable cases and flagged more than 1,000 instances of vision-threatening diabetic retinopathy.
Why it matters
- India has over 101 million people with diabetes, making diabetic retinopathy a major public health issue.
- MadhuNetrAI is deployed across 40 healthcare facilities covering 21 districts in 11 states.
- The win highlights the growing role of AI in India's public health screening programs.
The business
- Wadhwani AI is a not-for-profit institute working across health, agriculture, and education.
- MadhuNetrAI analyses retinal fundus images to detect and classify severity of diabetic retinopathy.
- It supports frontline healthcare workers like nurses, optometrists, and community health officers.
- The tool helps in image grading and triaging referable cases to specialists.
- It was developed in partnership with AIIMS Delhi and the Ministry of Health and Family Welfare.
In numbers
4,600+Applications to challenge · 2026
60+Countries represented in challenge · 2026
20,000Retinal images processed · 2026
10,000+Patients screened · 2026
40Healthcare facilities · 2026
21Districts covered · 2026
11States covered · 2026
3,000+Referable cases identified · 2026
1,000+Vision-threatening cases flagged · 2026
101 million+People with diabetes in India · 2026
What happens next
- The next step is deeper integration with national non-communicable disease screening frameworks under the Ministry of Health and Family Welfare.
Words to know
- retinal fundus images
- Photographs of the back of the eye, including the retina, blood vessels and optic disc.
- diabetic retinopathy
- A diabetes complication that damages blood vessels in the retina and can lead to blindness.
- triaging
- Sorting patients by urgency of medical need to prioritise treatment.
- referable cases
- Patients whose condition is serious enough to be sent to a specialist for further care.
The numbers around it
Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →
Other articles talking about it
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Wadhwani AI → · All startup news on 23 February 2026 →
Is this Wadhwani AI? Get your “Featured on StopDown” badge →